One study that included 1,553 patients also demonstrated a significant improvement in OS in patients with ES-SCLC with the addition of PD-1 and PD-L1 ICIs (HR: 0.76; 95% CI: 0.68–0.85) (22). This evidence concerns the gene PDCD1 and small cell lung carcinoma.